An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Houlihan Lokey (NYSE:HLI) has appointed Luiz Greca as Managing Director in its Healthcare Group, focusing on the Healthcare IT (HCIT) practice in the U.S., based in Miami. Greca brings nearly a decade of M&A and financial advisory experience from his previous role at William Blair & Company. His expertise aligns with the current active HCIT M&A market. The firm continues to be a leader in healthcare and technology advisory, noted for top rankings in M&A transactions under $1 billion.
Positive
Appointment of Luiz Greca as Managing Director enhances HCIT practice expertise.
Greca's experience in M&A and capital-raising transactions adds value to the firm.
Houlihan Lokey ranked No. 1 for healthcare M&A transactions under $1 billion in 2021.
Negative
None.
Luiz Greca Joins as a Managing Director in the Healthcare Group
MIAMI--(BUSINESS WIRE)--
Houlihan Lokey (NYSE:HLI), the global investment bank, announced today that Luiz Greca has joined the firm’s Healthcare Group as a Managing Director to lead the firm’s Healthcare IT (HCIT) practice in the U.S. He is based in the Miami office.
Mr. Greca joins from William Blair & Company, where he spent nearly a decade advising clients on M&A, corporate divestitures, and capital-raising transactions across the HCIT sector. Prior experience also includes roles at Bank of America in London and as an attorney.
“We are delighted that Luiz has joined us to lead our HCIT practice in the United States, particularly at a time when HCIT is among the most active segments of the healthcare M&A market. Luiz’s deep insights, expertise, and outstanding track record of success in delivering optimal solutions to his HCIT clients represent an excellent fit with our culture and our steadfast dedication to client service,” said Mark Francis, Global Head of Houlihan Lokey’s Healthcare Group.
"It is more important than ever to possess the deep domain expertise our clients require to navigate the challenges and opportunities in today’s market. Partnering Luiz with Frankfurt-based Raiko Stelten on our global HCIT coverage efforts will ensure a close collaboration between our market-leading industry groups to successfully deliver that domain expertise, along with the best advice and execution possible," said Phil Adams, Head of Global Technology at Houlihan Lokey.
Mr. Greca holds an MBA from the University of Chicago Booth School of Business and a J.D. from the Universidade Federal do Paraná in Brazil.
With 70 financial professionals in eight offices, Houlihan Lokey’s Healthcare Group has earned a reputation for providing superior service and achieving outstanding results in M&A advisory, capital raising, restructuring, and financial and valuation advisory. In 2021, the firm was ranked as the No. 1 global investment banking advisor for healthcare M&A transactions under $1 billion, according to Refinitiv.
Houlihan Lokey’s Technology Group is among the largest of its kind in financial services, with more than 200 financial professionals based in 14 offices around the world. In 2021, the firm was ranked as the No. 1 global investment banking advisor for all global technology transactions, according to Refinitiv, with 124 deals.
About Houlihan Lokey
Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and financial and valuation advisory. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. Houlihan Lokey is the No. 1 investment bank for all global M&A transactions, the No. 1 M&A advisor for the past seven consecutive years in the U.S., the No. 1 global restructuring advisor for the past eight consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 20 years, all based on number of transactions and according to data provided by Refinitiv.
